Amarin Corp Plcuk (AMRN) Long-Term Debt Repayments (2010 - 2020)
Amarin Corp Plcuk (AMRN) reported Long-Term Debt Repayments of $9.4 million for Q4 2020, down 7.75% year-over-year from $10.2 million in Q1 2020, and down 27.49% quarter-over-quarter from $13.0 million in Q3 2020.
Amarin Corp Plcuk (AMRN) Long-Term Debt Repayments (2010 - 2020) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 9 years of Long-Term Debt Repayments data on file, last reported at $9.4 million in Q4 2020.
- Long-Term Debt Repayments for Q4 2020 came in at $9.4 million, down 7.75% year-over-year; the trailing twelve-month figure through Dec 2020 was $50.3 million (up 59.03% YoY), and the FY2020 annual result was $50.3 million, up 59.03% from the prior year.
- Long-Term Debt Repayments fell to $9.4 million in Q4 2020 per AMRN's latest filing, from $13.0 million in the prior quarter.
- Over five years, Long-Term Debt Repayments peaked at $19.0 million in Q2 2019 and troughed at -$11.8 million in Q4 2017.
- A 4-year average of $7.1 million and a median of $9.2 million in 2019 frame the typical range for Long-Term Debt Repayments.
- On a YoY basis, Long-Term Debt Repayments climbed as much as 547.4% in 2019 and fell as far as 269.7% in 2019.
- A 4-year view of Long-Term Debt Repayments shows it stood at -$11.8 million in 2017, then soared by 135.22% to $4.2 million in 2018, then jumped by 145.99% to $10.2 million in 2019, then declined by 7.75% to $9.4 million in 2020.
- Business Quant data shows AMRN's Long-Term Debt Repayments at $9.4 million in Q4 2020, $13.0 million in Q3 2020, and $14.6 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 750.00 Mn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | - |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | - |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 1.14 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 833.00 Mn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 2.77 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 500.00 Mn |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 9.42 Mn |
| Dec 31, 2020 | 9.42 Mn |
| Sep 30, 2020 | 12.99 Mn |
| Sep 30, 2020 | 12.99 Mn |
| Jun 30, 2020 | 14.60 Mn |
| Jun 30, 2020 | 14.60 Mn |
| Mar 31, 2020 | 13.33 Mn |
| Mar 31, 2020 | 13.33 Mn |
| Dec 31, 2019 | 10.21 Mn |
| Dec 31, 2019 | 10.21 Mn |
| Sep 30, 2019 | 8.91 Mn |
| Sep 30, 2019 | 8.91 Mn |
| Jun 30, 2019 | 18.96 Mn |
| Jun 30, 2019 | 18.96 Mn |
| Mar 31, 2019 | -6.42 Mn |
| Mar 31, 2019 | -6.42 Mn |
| Dec 31, 2018 | 4.15 Mn |
| Dec 31, 2018 | 4.15 Mn |
| Sep 30, 2018 | 3.83 Mn |
| Sep 30, 2018 | 3.83 Mn |